Oral ganciclovir cost saving in CMV retinitis - German study data

  • Tracey Langsdale
Newsletter Article


T he value of information on the possible economic impact of a new drug or formulation before it is launched is well recognised. Researchers at the University of Hannover, Germany, have conducted a comparative study of the cost and quality-of-life effects of IV and oral ganciclovir in the treatment of cytomegalovirus (CMV) retinitis. Dr Susanne Wähling presented their findings at the International Health Economics Association Inaugural Conference [ Vancouver, Canada; May 1996 ].


Maintenance Therapy Ganciclovir Retinitis Oral Ganciclovir Ganciclovir Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1996

Authors and Affiliations

  • Tracey Langsdale

There are no affiliations available

Personalised recommendations